6 weeks of semaglutide How Fast Does Work? Week-by-Week Timeline & Results 6-Week Belly Weight Loss with

Tirzepatide was approved by the FDA for A1c lowering in Type 2 Diabetes in May 2022 Although it has not yet been approved for obesity, tirzepatide demonstrated significant weight reduction when analyzed as the secondary outcome in the SURPASS trials and as the primary outcome in the SURMOUNT I trial

A 2022 clinical trial followed about 200 people who had taken semaglutide for more than a year and lost an average of 17 percent of their body weight

Many patients experience greater appetite suppression and faster early weight loss with tirzepatide because it targets both GLP-1 and GIP receptors

Common adverse effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, which typically diminish over time as the body adjusts to treatment